side effects of glp-1 medications Long-Term Medications: What You Should Know glp 1 drug side effects

In adult NHANES (National Health and Nutrition Examination Survey) participants with diagnosed diabetes, glycemic control declined after more than a decade of progress, associated with a resurgence in vascular diabetic complications [23]

Some experts pointed to the prior authorization process as a potential hurdle

The slowdown came fast, steadily, and relentlessly, as seen in Intuitives subsequent quarterly commentary: Q323: In bariatrics, we continued to see double digit growth albeit at a modestly lower growth rate compared to Q2 Q423: We saw a continued deceleration in growth throughout 2023, likely the result of the uptake of GLP-1 drugs. Q124: Bariatric procedure growth continued to moderate and was flat year-over-year

Cardiovascular Outcomes This section reviews current evidence regarding GLP-1 RAs effects on MACE, PAD, CAD, HF, blood pressure, and AF, with detailed findings of trials and meta-analyses discussed in Tables 1 and 2 Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD

Heymsfield Although the latest anti-obesity agents are largely in the same class, head-to-head studies will demonstrate if people respond more to one drug vs

Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E